Britain’s competition regulator announced its decision not to pursue an in-depth investigation into Aviva’s acquisition of AIG Life UK, signaling a green light for the deal to proceed.
Aviva, one of the prominent players in the UK insurance market, reached an agreement last September to acquire the UK life insurance arm of American International Group (AIG) for a substantial sum of 460 million pounds ($580.43 million), as reported by Reuters.
The acquisition was poised to significantly bolster Aviva’s standing in the industry, with expectations to integrate approximately 1.3 million individual protection customers and 1.4 million group protection members into its existing business infrastructure, according to statements released by Aviva at the time of the deal.
Amidst this backdrop, Britain’s Competition and Markets Authority (CMA) made a crucial determination regarding the transaction. In a statement issued on Thursday, the CMA revealed its decision not to initiate a ‘phase 2’ investigation into the merger. This decision was made based on the information presently available to the regulator, as outlined under the provisions of the Enterprise Act 2002.
The CMA’s decision not to proceed with further investigation indicates a vote of confidence in the merger, suggesting that it does not raise significant concerns regarding competition within the UK insurance market.
Source: Reuters
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI